Q4 2021 Holdings
Filed 2022-01-19 | 24 holdings | $61.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $15.7M | 177,741 | 25.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $12.8M | 94,448 | 20.9% |
| Centene Corp(CNC) | COM | 15135B101 | $12.2M | 148,254 | 19.9% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $10.3M | 225,032 | 16.7% |
| Argenx SE(ARGX) | ADR | 04016X101 | $7.3M | 20,881 | 11.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.9M | 198,493 | 4.7% |
| Horizon Therapeutics PLC | COM | G46188101 | $14.8K | 137,610 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $13.5K | 26,844 | 0.0% |
| Iqvia Holdings Inc(IQV) | COM | 46266C105 | $12.5K | 44,314 | 0.0% |
| Bellus Health Inc(BLU) | COM | 07987C204 | $10.3K | 1,280,757 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $9.5K | 55,755 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $9.5K | 101,674 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $8.3K | 716,709 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.0K | 502,275 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.6K | 139,445 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $6.4K | 43,876 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $6.3K | 375,989 | 0.0% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $6.1K | 143,204 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $4.9K | 104,755 | 0.0% |
| Dice Molecules Holdings ORD | COM | 23345J104 | $4.7K | 185,201 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $3.0K | 369,134 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.3K | 97,680 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K200 | $860 | 2,731,044 | 0.0% |
| Bcls Acquisition Corp | COM | G0904B105 | $699 | 71,372 | 0.0% |